Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Equity Income (2020 - 2021)

Historic Equity Income for Insight Molecular Diagnostics (IMDX) over the last 2 years, with Q1 2021 value amounting to -$270000.0.

  • Insight Molecular Diagnostics' Equity Income rose 1793.31% to -$270000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was -$270000.0, marking a year-over-year increase of 8254.69%. This contributed to the annual value of -$270000.0 for FY2021, which is 8254.69% up from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Equity Income stood at -$270000.0 for Q1 2021, which was up 1793.31% from -$435000.0 recorded in Q4 2020.
  • Insight Molecular Diagnostics' 5-year Equity Income high stood at -$270000.0 for Q1 2021, and its period low was -$482000.0 during Q3 2020.